Unlocking Therapeutic Potential

Nuformix is a pharmaceutical development company focused on unlocking the therapeutic potential and value of known drugs to develop new novel medicines to provide enhanced benefit with  lead programmes in fibrosis and oncology supportive care .

Company Overview

Chris Blackwell, Executive Chairman, Preliminary Results for the year ended 31 March 2020; Proactive Investors Interview